Amlodipine as adjuvant therapy to current chelating agents for reducing iron overload in thalassaemia major: a systematic review, meta‐analysis and simulation of future studies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Amlodipine as adjuvant therapy to current chelating agents for reducing iron overload in thalassaemia major: a systematic review, meta‐analysis and simulation of future studies

Published:2021-02-26 Issue:8 Volume:116 Page:887-897
ISSN:0042-9007
Container-title:Vox Sanguinis
language:en
Short-container-title:Vox Sang

Author:

Elfaituri Muhammed Khaled¹²,Ghozy Sherief²³⁴^ORCID,Ebied Amr²⁵^ORCID,Morra Mostafa Ebraheem²⁶,Hassan Osama Gamal²⁷,Alhusseiny Ahmed²³,Abbas Alzhraa Salah²⁸,Sherif Nourin Ali²³,Fernandes Juliano Lara⁹,Huy Nguyen Tien¹⁰¹¹^ORCID

Affiliation:

1. Faculty of Medicine University of Tripoli Tripoli Libya

2. Online Research Club Nagasaki Japan

3. Faculty of Medicine Mansoura University Mansoura Egypt

4. Neurosurgery Department El Sheikh Zayed Specialized Hospital Giza Egypt

5. Egyptian National Blood Transfusion Services Alexandria Egypt

6. Faculty of Medicine Al‐Azhar University Cairo Egypt

7. Faculty of Medicine South Valley University Qena Egypt

8. Faculty of Medicine Minia University Minia Egypt

9. Jose Michel Kalaf Research Institute Radiologia Clinica de Campinas Sao Paulo Brazil

10. Institute of Research and Development Duy Tan University Da Nang Vietnam

11. School of Tropical Medicine and Global Health Nagasaki University Nagasaki Japan

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/vox.13083

Reference38 articles.

1. Thalassemia and malignancy: An emerging concern?

2. Role of some members of chemokine/cytokine network in the pathogenesis of thalassemia and sickle cell hemoglobinopathies: a mini review

3. Optimizing the diagnosis and the treatment of iron overload diseases

4. Iron and the heart: A paradigm shift from systemic to cardiomyocyte abnormalities

5. A Randomized, Placebo-Controlled, Double-Blind Trial of the Effect of Combined Therapy With Deferoxamine and Deferiprone on Myocardial Iron in Thalassemia Major Using Cardiovascular Magnetic Resonance

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amlodipine Therapy in β-Thalassemia Patients: A Systematic Review and Meta-Analysis on Ferritin Levels and Liver MRI T2*;Thalassemia Reports;2023-12-11

2. Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia;Cochrane Database of Systematic Reviews;2023-11-17

3. Cardiovascular Complications in β-Thalassemia: Getting to the Heart of It;Thalassemia Reports;2023-01-30

4. Efficacy and safety of calcium channel blockers in preventing cardiac siderosis in thalassemia patients: An updated meta‐analysis with trial sequential analysis;European Journal of Haematology;2023-01-02

5. Comparison of the effects of calcium channel blockers plus iron chelation therapy versus chelation therapy only on iron overload in children and young adults with transfusion‐dependent thalassemia: A randomized double‐blind placebo‐controlled trial;Pediatric Blood & Cancer;2022-01-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3